United Asset Strategies, Inc. Zoetis Inc. Transaction History

United Asset Strategies, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$151.44 - $200.09 $11,812 - $15,607	-78 Reduced 1.05%	7,355 $1.45 Million
Q3 2023 Nov 07, 2023	BUY	$167.14 - $192.77 $1.24 Million - $1.43 Million	7,433 New	7,433 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $33,845 - $43,419	217 Added 3.33%	6,739 $1.16 Million
Q1 2022 Apr 29, 2022	BUY	$181.39 - $234.03 $98,494 - $127,078	543 Added 9.08%	6,522 $1.23 Million
Q4 2021 Jan 31, 2022	BUY	$193.69 - $247.03 $103,817 - $132,408	536 Added 9.85%	5,979 $1.46 Million
Q3 2021 Oct 21, 2021	BUY	$189.29 - $209.69 $1.03 Million - $1.14 Million	5,443 New	5,443 $1.06 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on United Asset Strategies, Inc. with notifications on news.